人结肠癌细胞系SP细胞microRNA表达谱的初步分析

doi:10.3969/j.issn.1000-4718.2014.07.006

摘要
图/表
参考文献(0)
相关文章 (15)

全文: PDF (1267 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要

目的：探讨结肠癌侧群（SP）细胞在结肠癌多药耐药性中的作用及其microRNA生物标志。方法：结肠癌SP细胞的分选采用流式细胞术，细胞活力的测定采用MTT法，microRNA表达谱的检测采用microRNA芯片，microRNA表达的验证采用实时荧光定量PCR。结果：（1）HCT-15、HT-29及LoVo结肠癌细胞系中SP细胞的比例分别为16.75%、13.02%及9.52%。（2）化疗药（5-氟尿嘧啶、草酸铂及阿霉素）对3种结肠癌细胞系SP细胞的 IC50均明显高于对非SP细胞的IC50（P<0.05）。（3）microRNA芯片检测表明miR-5000-3p、miR-5009-3p及miR-552在3种结肠癌细胞系的SP细胞中表达均上调，实时荧光定量PCR亦证实此结果。结论：miR-5000-3p、miR-5009-3p及miR-552在结肠癌细胞系的SP细胞中表达上调，有可能成为结肠癌SP细胞的潜在microRNA生物标志。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	夏忠胜
	钟娃
	于涛
	练国达
	周慧敏
	陈广成

关键词 ：结肠肿瘤, 侧群细胞, 微小RNA, miR-5000-3p, miR-5009-3p, miR-552

Abstract：

AIM：To investigate the role of side population (SP) cells in multidrug resistance of colon cancer cells and microRNA biomarkers of SP cells in colon cancer cells. METHODS：SP cells in colon cancer cells were sorted by flow cytometry. The cell viability was measured by MTT method. MicroRNA expression profiles were detected by microRNA chip. MicroRNA expression was verified by real-time PCR. RESULTS：The ratios of SP cells in HCT-15, HT-29 and LoVo colon cancer cell lines were 16.75%, 13.02% and 9.52%, respectively. In all 3 colon cancer cell lines, IC50 of the antitumor drugs including 5-fluorouracil, oxaliplatin and adriamycin for the SP cells were significantly higher than those for non-SP cells (P<005). MicroRNA profiling showed that miR-5000-3p, miR-5009-3p and miR-552 were all up-regulated in the SP cells of all 3 colon cancer cell lines. This result was verified by real-time PCR. CONCLUSION：miR-5000-3p, miR-5009-3p and miR-552 are all up-regulated in the SP cells of colon cancer cell lines, and may be the potential microRNA biomarkers of SP cells in colon cancer.

Key words： Colonic neoplasms Side population cells MicroRNA miR-5000-3p miR-5009-3p miR-552

收稿日期: 2014-01-20 出版日期: 2014-07-15

中图分类号:

R363

基金资助:

广东省自然科学基金资助项目（No. 9451008901002424）

通讯作者: 夏忠胜 E-mail: xiazhsh@163.com

引用本文:

夏忠胜，钟娃，于涛，练国达，周慧敏，陈广成. 人结肠癌细胞系SP细胞microRNA表达谱的初步分析[J]. 中国病理生理杂志, 2014, 30(7): 1184-1191. XIA Zhong-sheng, ZHONG Wa, YU Tao, LIAN Guo-da, ZHOU Hui-min, CHEN Guang-cheng. Priliminary analysis of microRNA expression profiles of side population cells in human colon cancer cell lines. Chin J Pathophysiol, 2014, 30(7): 1184-1191.

链接本文:

http://www.cjpp.net/CN/10.3969/j.issn.1000-4718.2014.07.006 或 http://www.cjpp.net/CN/Y2014/V30/I7/1184

［1］	Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal can-cer: a multicentre randomised trial［J］. Lancet, 2000, 355(9209): 1041-1047.
［2］	van den Heuvel-Eibrink MM, Sonneveld P, Pieters R. The prognostic significance of membrane transport-asso-ciated multidrug resistance (MDR) proteins in leukemia［J］. Int J Clin Pharmacol Ther, 2000, 38(3): 94-110.
［3］	夏忠胜, 朱兆华, 陈其奎, 等. 靶向MDR1基因的RNAi稳定逆转结肠癌细胞的多药耐药性［J］. 中国病理生理杂志, 2009, 25(5): 898-903.
［4］	Todaro M, Francipane MG, Medema JP, et al. Colon cancer stem cells: promise of targeted therapy［J］. Gastroenterology, 2010, 138(6): 2151-2162.
［5］	Zheng X, Shen G, Yang X, et al. Most C6 cells are can-cer stem cells: evidence from clonal and population analyses［J］. Cancer Res, 2007, 67(8): 3691-3697.
［6］	Szotek PP, Pieretti-Vanmarche R, Masiakos PT, et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness［J］. Proc Natl Acad Sci U S A, 2006, 103(30): 11154-11159.
［7］	Zhou S, Schuetz JD, Bunting KD, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype［J］. Nat Med, 2001, 7(9): 1028-1034.
［8］	Behbod F, Xian W, Shaw CA, et al. Transcriptional profiling of mammary gland side population cells［J］. Stem Cells, 2006, 24(4): 1065-1074.
［9］	Goodell MA, Brose K, Paradis G, et al. Isolation and functional propertied of murine hematopoietic stem cells that are replicating in vivo［J］. J Exp Med, 1996, 183(4): 1797-1806.
［10］	Haraguchi N, Utsunomiya T, Inoue H, et al. Characterization of a side population of cancer cells from human gastrointestinal system［J］. Stem Cells, 2006, 24(3): 506-513.
［11］	Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma［J］. JAMA, 2008, 299(4): 425-436.
［12］	Callari M, Dugo M, Musella V, et al. Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues［J］. PLoS One, 2012, 7(9): e45105.
［13］	Inoda S, Hirohashi Y, Torigoe T, et al. Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells［J］. Am J Pathol, 2011, 178(4): 1805-1813.
［14］	Alexander L, Francesc B, Yan S, et al. Fecal microRNAs as novel biomarkers for colon cancer screening［J］. Cancer Epidemiol Biomarkers Prev, 2010, 19(7): 1766-1774.
［15］	Hofsli E, Sjursen W, Prestvik WS, et al. Identification of serum microRNA profiles in colon cancer［J］. Br J Can-cer, 2013, 108(8): 1712-1719.
［16］	Zhang H, Li W, Nan F, et al. MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line［J］. Biochem Biophys Res Commun, 2011, 404(1): 273-278.
［17］	Fang Y, Xiang J, Chen ZY, et al. miRNA expression profile of colon cancer stem cells compared to non-stem cells using the SW1116 cell line［J］. Oncol Rep, 2012, 28(6): 2115-2124.